Media

Press releases

Regulatory

November 27, 2023

Amniotics AB (publ) Report for the third Quarter 2023

Non-Regulatory

November 23, 2023

Renewed GMP certification

Regulatory

November 20, 2023

Amniotics receives positive opinion on orphan designation for PulmoStem® from the European Medicines Agency for the Treatment of Primary Graft Dysfunction following Lung Transplantation

Non-Regulatory

November 17, 2023

Last day of trading in paid subscribed units in Amniotics

Regulatory

October 27, 2023

Amniotics announces outcome in rights issue

Non-Regulatory

October 11, 2023

The subscription period in Amniotics’ rights issue commences today

Regulatory

October 10, 2023

Amniotics publishes prospectus in connection with the rights issue of approximately SEK 25 million

Non-Regulatory

September 26, 2023

Amniotics granted Singapore patent for its amniotic fluid collection technology

Non-Regulatory

September 13, 2023

Final Clinical Study Report received for PulmoStem Phase Ib clinical trial

Regulatory

September 6, 2023

Amniotics procures top guarantee commitments and enters into additional subscription undertakings for a fully secured rights issue

Upcoming events